Percutaneous atrial septal defect closure in Ebstein’s anomaly

Abstract

We report a patient with Ebstein’s anomaly, on chronic milrinone therapy for right ventricular failure, who underwent palliative percutaneous closure of her atrial septal defect (ASD) due to recurring strokes. Repeated evaluation of right-sided pressures was performed prior to ASD closure to determine if our patient could tolerate the intervention. Definitive ASD closure was performed under fluoroscopic and transesophageal echocardiogram guidance.

KEYWORDS:

• Atrial septal defect
• Ebstein anomaly
• right ventricular failure
• stroke
• tricuspid regurgitation

Disclosure statement/Funding

The authors report no funding. Dr. Al-Azizi reports consultant work with Philips Volcano and Edwards Life Science; the other authors have no potential conflicts to disclose. The patient provided permission for this case to be published.